Last 50.75 GBp
Change Today 0.00 / 0.00%
Volume 52.2K
FUM On Other Exchanges
As of 11:30 AM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

futura medical plc (FUM) Snapshot

50.75 GBp
Previous Close
50.75 GBp
Day High
50.75 GBp
Day Low
50.75 GBp
52 Week High
09/10/13 - 82.50 GBp
52 Week Low
11/14/13 - 49.25 GBp
Market Cap
Average Volume 10 Days
-0.03 GBp
Shares Outstanding
Dividend Yield
Current Stock Chart for FUTURA MEDICAL PLC (FUM)

Related News

No related news articles were found.

futura medical plc (FUM) Related Businessweek News

No Related Businessweek News Found

futura medical plc (FUM) Details

Futura Medical plc is engaged in the research and development of pharmaceutical drugs and medical devices in the United Kingdom. The company offers CSD500, a condom that incorporates an erectogenic compound to help men maintain a firmer erection during intercourse whilst wearing a condom; MED2002, a gel applied directly to the penis for the treatment of male erectile dysfunction; and PET500, a topical spray that enables men to prolong their sexual experience. Its pain relief management products, such as TPR100 and TIB200 incorporates a non-steroidal anti-inflammatory drug; and SPR300 a topical gel combines methyl salicylate and menthol. The company is headquartered in Guildford, the United Kingdom.

6 Employees
Last Reported Date: 03/28/14

futura medical plc (FUM) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: 199.8K GBP
Finance Director, Secretary, Financial Contro...
Total Annual Compensation: 129.7K GBP
Chief Scientific Officer and Adviser to the B...
Total Annual Compensation: --
Chief Development Officer and Executive Direc...
Total Annual Compensation: 165.1K GBP
Compensation as of Fiscal Year 2013.

futura medical plc (FUM) Key Developments

Futura Medical plc, Annual General Meeting, May 13, 2014

Futura Medical plc, Annual General Meeting, May 13, 2014., at 16:00 GMT Standard Time. Location: Buchanan, 107 Cheapside.

Futura Medical plc Announces Audited Group Earnings Results for the Year Ended December 31, 2013

Futura Medical plc announced audited group earnings results for the year ended December 31, 2013. For the year, the company reported revenues of £370,902 against £75,000 a year ago. Operating loss was £2,531,543 against £2,455,928 a year ago. Loss before tax was £2,522,009 against £2,437,440 a year ago. Total comprehensive loss for the year attributable to owners of the parent company was £2,208,332 against £2,176,649 a year ago. Basic and diluted loss per share was 2.85 pence against 2.91 pence a year ago. Net cash used in operating activities were £2,013,958 against £1,940,808 a year ago. Purchase of plant and equipment was £5,048 against £4,246 a year ago.

Futura Medical plc, Annual General Meeting, Mar 25, 2014

Futura Medical plc, Annual General Meeting, Mar 25, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FUM:LN 50.75 GBp 0.00

FUM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FUM.
View Industry Companies

Industry Analysis


Industry Average

Valuation FUM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 109.5x
Price/Book 41.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 139.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FUTURA MEDICAL PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at